monoaminocarboxydihydroborane: RN given is for 10B isotope [MeSH]
| ID Source | ID |
|---|---|
| PubMed CID | 6336339 |
| MeSH ID | M0161793 |
| Synonym |
|---|
| monoaminocarboxydihydroborane |
| 98169-69-8 |
| madb |
| monoamino-carboxy-dihydro-borane |
| QAQRGFVQHREOLN-UHFFFAOYSA-N |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| erythrosine | 2002 | 2002 | 22.0 | medium | 0 | 0 | 0 | 1 | 0 | 0 | |||
| boric acid | boric acids | astringent | 1988 | 1988 | 36.0 | medium | 0 | 1 | 0 | 0 | 0 | 0 | |
| 6-carboxyfluorescein | monocarboxylic acid | 2002 | 2002 | 22.0 | medium | 0 | 0 | 0 | 1 | 0 | 0 | ||
| lonafarnib | 4-{2-[4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl]-2-oxoethyl}piperidine-1-carboxamide | antineoplastic agent; EC 2.5.1.58 (protein farnesyltransferase) inhibitor | 2023 | 2023 | 1.0 | high | 0 | 0 | 0 | 0 | 0 | 1 | |
| baricitinib | azetidines; nitrile; pyrazoles; pyrrolopyrimidine; sulfonamide | anti-inflammatory agent; antirheumatic drug; antiviral agent; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; immunosuppressive agent | 2023 | 2023 | 1.0 | high | 0 | 0 | 0 | 0 | 0 | 1 |
| Condition | Indicated | Studies | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adenocarcinoma | 0 | 2002 | 2002 | 22.0 | medium | 0 | 0 | 0 | 1 | 0 | 0 | |
| Adenocarcinoma, Basal Cell | 0 | 2002 | 2002 | 22.0 | medium | 0 | 0 | 0 | 1 | 0 | 0 | |
| Cancer of Lung | 0 | 2002 | 2002 | 22.0 | medium | 0 | 0 | 0 | 1 | 0 | 0 | |
| Hutchinson Gilford Progeria Syndrome | 0 | 2023 | 2023 | 1.0 | medium | 0 | 0 | 0 | 0 | 0 | 1 | |
| Lipodystrophy | 0 | 2023 | 2023 | 1.0 | medium | 0 | 0 | 0 | 0 | 0 | 1 | |
| Lung Neoplasms | 0 | 2002 | 2002 | 22.0 | medium | 0 | 0 | 0 | 1 | 0 | 0 | |
| Progeria | 0 | 2023 | 2023 | 1.0 | medium | 0 | 0 | 0 | 0 | 0 | 1 |